AAAAAA
Results:
1-20
|
Results: 20
Authors:
Gravis, G
Mousseau, M
Douillard, JY
Dorval, T
Fabbro, M
Escudier, B
Mignot, L
Viens, P
Citation: G. Gravis et al., Can interleukin-2 reverse anthracyclin chemoresistance in metastatic soft tissue sarcoma patients. Results of a prospective phase II clinical trial, EUR CYTOKIN, 12(2), 2001, pp. 239-243
Authors:
Georgoulias, V
Scagliotti, G
Miller, V
Eckardt, J
Douillard, JY
Manegold, C
Citation: V. Georgoulias et al., Challenging the platinum combinations: Docetaxel (Taxotere) combined with gemcitabine or vinorelbine in non-small cell lung cancer, SEMIN ONCOL, 28(1), 2001, pp. 15-21
Authors:
Van Cutsem, E
Douillard, JY
Kohne, C
Citation: E. Van Cutsem et al., Toxicity of irinotecan in patients with colorectal cancer., N ENG J MED, 345(18), 2001, pp. 1351-1352
Authors:
Bardet, E
Moro-Sibilot, D
Le Chevalier, T
Massard, G
Douillard, JY
Theobald, S
Astoul, P
Baldeyrou, P
Bazelly, B
Brechot, J
Breton, JL
Grivaux, M
Jacoulet, P
Khalil, A
Lemarie, E
Martinet, Y
Milleron, B
Paesmans, M
Pujol, JL
Quoix, AE
Ranfaing, E
Riviere, A
Sancho-Garnier, H
Souquet, PJ
Spaeth, D
Stoebner-Delbarre, A
Thiberville, L
Touboul, E
Vaylet, F
Vergnon, JM
Westeel, V
Depierre, A
Lagrange, JL
Citation: E. Bardet et al., Standards, Options and Recommendations for the management of locally advanced non small cell lung carcinoma, B CANCER, 88(4), 2001, pp. 369-387
Authors:
Douillard, JY
Lerouge, D
Monnier, A
Bennouna, J
Haller, AM
Sun, XS
Assouline, D
Grau, B
Riviere, A
Citation: Jy. Douillard et al., Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study, BR J CANC, 84(9), 2001, pp. 1179-1184
Authors:
Bennouna, J
Monnier, A
Riviere, A
Milleron, B
Lemarie, E
Trillet-Lenoir, V
Soussan-Lazard, K
Berille, J
Douillard, JY
Citation: J. Bennouna et al., A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer, EUR J CANC, 36(9), 2000, pp. 1107-1112
Authors:
Douillard, JY
Citation: Jy. Douillard, Irinotecan and high-dose fluorouracil/leucovorin for metastatic colorectalcancer, ONCOLOGY-NY, 14(12), 2000, pp. 51-55
Authors:
Negrier, S
Caty, A
Lesimple, T
Douillard, JY
Escudier, B
Rossi, JF
Viens, P
Gomez, F
Citation: S. Negrier et al., Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil, J CL ONCOL, 18(24), 2000, pp. 4009-4015
Authors:
Douillard, JY
Bennouna, J
Vavasseur, F
Deporte-Fety, R
Thomare, P
Giacalone, F
Meflah, K
Citation: Jy. Douillard et al., Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancer, CANCER IMMU, 49(1), 2000, pp. 56-61
Authors:
Bennouna, J
Bardet, E
Deguiral, P
Douillard, JY
Citation: J. Bennouna et al., Small cell carcinoma of the esophagus - Analysis of 10 cases and review ofthe published data, AM J CL ONC, 23(5), 2000, pp. 455-459
Authors:
Ychou, M
Douillard, JY
Rougier, P
Adenis, A
Mousseau, M
Dufour, P
Wendling, JL
Burki, F
Mignard, D
Marty, M
Citation: M. Ychou et al., Randomized comparison of prophylactic antidiarrheal treatment versus no prophylactic antidiarrheal treatment in patients receiving CPT-11 (irinotecan) for advanced 5-FU-resistant colorectal cancer - An open-label multicenterphase II study, AM J CL ONC, 23(2), 2000, pp. 143-148
Authors:
Mattson, K
Bosquee, L
Dabouis, G
Le Groumellec, A
Pujol, JL
Marien, S
Stupp, R
Douillard, JY
Bragas, B
Berille, J
Olivares, R
Le Chevalier, T
Citation: K. Mattson et al., Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice, LUNG CANC, 29(3), 2000, pp. 205-216
Authors:
Douillard, JY
Citation: Jy. Douillard, Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer (vol 355, pg 1041, 2000), LANCET, 355(9212), 2000, pp. 1372-1372
Authors:
Douillard, JY
Cunningham, D
Roth, AD
Navarro, M
James, RD
Karasek, P
Jandik, P
Iveson, T
Carmichael, J
Alakl, M
Gruia, G
Awad, L
Rougier, P
Citation: Jy. Douillard et al., Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial, LANCET, 355(9209), 2000, pp. 1041-1047
Authors:
Vuillez, JP
Kraeber-Bodere, F
Moro, D
Bardies, M
Douillard, JY
Gautherot, E
Rouvier, E
Barbet, J
Garban, F
Moreau, P
Chatal, JF
Citation: Jp. Vuillez et al., Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: Results of a phase I/II trial, CLIN CANC R, 5(10), 1999, pp. 3259S-3267S
Authors:
Douillard, JY
Citation: Jy. Douillard, Postoperative adjuvant treatments, REV MAL RES, 16, 1999, pp. S127-S128
Authors:
Escudier, B
Chevreau, C
Lasset, C
Douillard, JY
Ravaud, A
Fabbro, M
Caty, A
Rossi, JF
Viens, P
Bergerat, JP
Savary, J
Negrier, S
Citation: B. Escudier et al., Cytokines in metastatic renal cell carcinoma: Is it useful to switch to interleukin-2 or interferon after failure of a first treatment?, J CL ONCOL, 17(7), 1999, pp. 2039-2043
Authors:
Le Chevalier, T
Berille, J
Zalcberg, JR
Millward, MJ
Monnier, A
Douillard, JY
McKeage, MJ
James, R
Soulas, F
Loret, C
Bougon, N
Bizzari, JP
Citation: T. Le Chevalier et al., Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer, SEMIN ONCOL, 26(3), 1999, pp. 13-18
Authors:
Le Chevalier, T
Monnier, A
Douillard, JY
Ruffie, P
Sun, XS
Belli, L
Ibrahim, N
Bougon, N
Berille, J
Citation: T. Le Chevalier et al., Docetaxel (Taxotere((R))) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer, EUR J CANC, 34(13), 1998, pp. 2032-2036
Authors:
Douillard, JY
Chatal, JF
Citation: Jy. Douillard et Jf. Chatal, Monoclonal antibodies and their fragments in cancer treatment, B CANCER, 85(11), 1998, pp. 951-959
Risultati:
1-20
|